tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Co (TKPHF)
:TKPHF
US Market
Advertisement

Takeda Pharmaceutical Co (TKPHF) Ratios

Compare
35 Followers

Takeda Pharmaceutical Co Ratios

TKPHF's free cash flow for Q1 2025 was ¥0.65. For the 2025 fiscal year, TKPHF's free cash flow was decreased by ¥ and operating cash flow was ¥0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.16 1.11 0.97 1.21 1.53
Quick Ratio
0.59 0.58 0.57 0.81 1.10
Cash Ratio
0.16 0.20 0.21 0.40 0.54
Solvency Ratio
0.12 0.11 0.13 0.11 0.12
Operating Cash Flow Ratio
0.49 0.31 0.39 0.52 0.57
Short-Term Operating Cash Flow Coverage
2.89 1.95 2.88 5.51 45.63
Net Current Asset Value
¥ -4.63T¥ -5.28T¥ -5.21T¥ -4.90T¥ -5.02T
Leverage Ratios
Debt-to-Assets Ratio
0.32 0.32 0.31 0.33 0.36
Debt-to-Equity Ratio
0.66 0.67 0.69 0.76 0.90
Debt-to-Capital Ratio
0.40 0.40 0.41 0.43 0.47
Long-Term Debt-to-Capital Ratio
0.38 0.38 0.39 0.42 0.47
Financial Leverage Ratio
2.04 2.08 2.20 2.32 2.50
Debt Service Coverage Ratio
1.84 1.85 2.21 3.00 3.67
Interest Coverage Ratio
1.57 1.39 2.89 2.77 2.05
Debt to Market Cap
0.68 0.74 0.65 0.79 0.74
Interest Debt Per Share
3.04K 3.19K 2.93K 2.89K 3.13K
Net Debt to EBITDA
3.43 5.01 3.25 2.95 3.73
Profitability Margins
Gross Profit Margin
60.54%66.43%69.11%68.99%68.91%
EBIT Margin
10.28%4.04%12.22%11.91%15.54%
EBITDA Margin
27.04%20.51%29.41%33.15%30.76%
Operating Profit Margin
9.05%5.02%12.18%12.91%15.93%
Pretax Profit Margin
4.24%1.24%9.31%8.48%11.45%
Net Profit Margin
3.06%3.38%7.87%6.45%11.76%
Continuous Operations Profit Margin
3.06%3.38%8.09%6.88%11.76%
Net Income Per EBT
72.10%272.90%84.52%76.03%102.67%
EBT Per EBIT
46.84%24.66%76.47%65.66%71.91%
Return on Assets (ROA)
0.98%0.95%2.27%1.75%2.91%
Return on Equity (ROE)
1.95%1.98%4.99%4.05%7.27%
Return on Capital Employed (ROCE)
3.43%1.67%4.27%4.18%4.57%
Return on Invested Capital (ROIC)
2.41%4.42%3.49%3.11%4.67%
Return on Tangible Assets
2.59%2.66%6.47%4.65%7.57%
Earnings Yield
2.06%2.21%4.70%4.21%6.04%
Efficiency Ratios
Receivables Turnover
6.59 6.11 5.91 4.93 3.93
Payables Turnover
4.53 4.47 4.05 3.74 4.28
Inventory Turnover
1.54 1.18 1.26 1.30 1.32
Fixed Asset Turnover
2.29 2.14 2.38 2.25 2.20
Asset Turnover
0.32 0.28 0.29 0.27 0.25
Working Capital Turnover Ratio
25.01 52.80 22.13 5.14 5.19
Cash Conversion Cycle
211.93 286.63 260.99 257.84 284.30
Days of Sales Outstanding
55.36 59.72 61.78 74.08 92.76
Days of Inventory Outstanding
237.08 308.49 289.42 281.35 276.74
Days of Payables Outstanding
80.51 81.58 90.20 97.59 85.20
Operating Cycle
292.44 368.21 351.20 355.43 369.51
Cash Flow Ratios
Operating Cash Flow Per Share
684.97 457.89 629.69 718.33 647.20
Free Cash Flow Per Share
531.34 150.61 221.33 599.34 495.81
CapEx Per Share
139.59 307.28 408.36 118.99 151.39
Free Cash Flow to Operating Cash Flow
0.78 0.33 0.35 0.83 0.77
Dividend Paid and CapEx Coverage Ratio
2.03 0.93 1.07 2.39 1.94
Capital Expenditure Coverage Ratio
4.91 1.49 1.54 6.04 4.28
Operating Cash Flow Coverage Ratio
0.24 0.15 0.22 0.26 0.22
Operating Cash Flow to Sales Ratio
0.24 0.17 0.24 0.31 0.32
Free Cash Flow Yield
12.53%3.62%5.09%17.13%12.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
48.16 45.16 21.29 23.77 16.55
Price-to-Sales (P/S) Ratio
1.47 1.53 1.68 1.53 1.95
Price-to-Book (P/B) Ratio
0.96 0.89 1.06 0.96 1.20
Price-to-Free Cash Flow (P/FCF) Ratio
7.92 27.62 19.65 5.84 8.04
Price-to-Operating Cash Flow Ratio
6.15 9.08 6.91 4.87 6.16
Price-to-Earnings Growth (PEG) Ratio
1.77 -0.82 0.55 -0.61 0.02
Price-to-Fair Value
0.96 0.89 1.06 0.96 1.20
Enterprise Value Multiple
8.86 12.45 8.95 7.58 10.06
Enterprise Value
10.79T 10.89T 10.60T 8.96T 9.89T
EV to EBITDA
8.91 12.45 8.95 7.58 10.06
EV to Sales
2.41 2.55 2.63 2.51 3.09
EV to Free Cash Flow
12.98 46.23 30.86 9.57 12.77
EV to Operating Cash Flow
10.07 15.21 10.85 7.98 9.79
Tangible Book Value Per Share
-1.18K -1.54K -1.74K -1.63K -1.77K
Shareholders’ Equity Per Share
4.39K 4.65K 4.09K 3.63K 3.31K
Tax and Other Ratios
Effective Tax Rate
0.27 -1.73 0.15 0.24 -0.03
Revenue Per Share
2.86K 2.73K 2.60K 2.28K 2.05K
Net Income Per Share
87.51 92.09 204.29 147.14 240.72
Tax Burden
0.72 2.73 0.85 0.76 1.03
Interest Burden
0.41 0.31 0.76 0.71 0.74
Research & Development to Revenue
0.16 0.17 0.16 0.15 0.14
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.02 0.02 0.01 0.01
Income Quality
7.82 4.97 3.08 4.88 2.69
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis